| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association of Cardiomyopathy With Adverse Cardiac Events in Pregnant Women at the Time of Delivery
|
Lima, Fabio V.
|
|
2015
|
3 |
3 |
p. 257-266
10 p.
|
artikel
|
| 2 |
Coenzyme Q10
|
Mortensen, Svend Aage
|
|
2015
|
3 |
3 |
p. 270-271
2 p.
|
artikel
|
| 3 |
Early and Late Effects of High- Versus Low-Dose Angiotensin Receptor Blockade on Renal Function and Outcomes in Patients With Chronic Heart Failure
|
Kiernan, Michael S.
|
|
2015
|
3 |
3 |
p. 214-223
10 p.
|
artikel
|
| 4 |
Effect of Ivabradine on Early Readmissions After Hospitalization for Worsening Heart Failure
|
Borer, Jeffrey S.
|
|
2015
|
3 |
3 |
p. 268-269
2 p.
|
artikel
|
| 5 |
Evolving Role of Galectin-3 as a Cardiac Biomarker
|
deFilippi, Christopher R.
|
|
2015
|
3 |
3 |
p. 253-256
4 p.
|
artikel
|
| 6 |
Galectin-3 in Heart Failure With Preserved Ejection Fraction
|
AbouEzzeddine, Omar F.
|
|
2015
|
3 |
3 |
p. 245-252
8 p.
|
artikel
|
| 7 |
Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor
|
Felker, G. Michael
|
|
2015
|
3 |
3 |
p. 193-201
9 p.
|
artikel
|
| 8 |
Hop, Skip, and Jump
|
O’Connor, Christopher M.
|
|
2015
|
3 |
3 |
p. 273-274
2 p.
|
artikel
|
| 9 |
How Many Patients Will Benefit From a New Therapy for Chronic Systolic Heart Failure, and What Difference Does it Make? ∗
|
Borer, Jeffrey S.
|
|
2015
|
3 |
3 |
p. 231-233
3 p.
|
artikel
|
| 10 |
Improvement in Cardiac Energetics by Perhexiline in Heart Failure Due to Dilated Cardiomyopathy
|
Beadle, Roger M.
|
|
2015
|
3 |
3 |
p. 202-211
10 p.
|
artikel
|
| 11 |
Incidence, Temporal Trends, and Prognostic Impact of Heart Failure Complicating Acute Myocardial Infarction
|
Desta, Liyew
|
|
2015
|
3 |
3 |
p. 234-242
9 p.
|
artikel
|
| 12 |
Inside This Issue
|
|
|
2015
|
3 |
3 |
p. A15-A18
nvt p.
|
artikel
|
| 13 |
Instructions For Authors
|
|
|
2015
|
3 |
3 |
p. A11-A14
nvt p.
|
artikel
|
| 14 |
Perhexiline: Lessons for Heart Failure Therapeutics ∗
|
Cappola, Thomas P.
|
|
2015
|
3 |
3 |
p. 212-213
2 p.
|
artikel
|
| 15 |
Prescribing Patterns to Optimize Heart Rate
|
Dierckx, Riet
|
|
2015
|
3 |
3 |
p. 224-230
7 p.
|
artikel
|
| 16 |
Reply
|
Gheorghiade, Mihai
|
|
2015
|
3 |
3 |
p. 269-270
2 p.
|
artikel
|
| 17 |
Reply
|
Ezekowitz, Justin A.
|
|
2015
|
3 |
3 |
p. 271-272
2 p.
|
artikel
|
| 18 |
Risk Prediction Tools in Patients With Heart Failure
|
Lupón, Josep
|
|
2015
|
3 |
3 |
p. 267-
1 p.
|
artikel
|
| 19 |
Standing the Test of Time ∗
|
Lala, Anuradha
|
|
2015
|
3 |
3 |
p. 243-244
2 p.
|
artikel
|
Tijdschrift beschrijving